Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Ryanair upgrades expectations

HeiQ forecasts slashed

AIM movers: Corcel farm-out and United Oil & Gas disappointment

AIM movers: GENinCode gains US lab approval and Bidstack dispute

New Year prospects: Windward Ltd

New Year prospects: ProCook Group

Aquis weekly movers: Invinity Energy Systems upgrade

New Year prospects: Blackbird

AIM weekly movers: Indicative proposals for Applied Graphene Materials

New Year prospects: CMO Group

Positive trial data for Celadon Pharmaceuticals

AIM movers: Catenae Innovations returns from suspension and Pantheon Resources share price slump

Catalyst Media NAV trebles

AIM movers: Allergy Therapeutics accounts delayed and ex-dividends

New Year prospects: Tribal Group

New Year prospects: Cake Box

AIM movers: Polarean Imaging gains FDA approval

Argo Blockchain secures future

New Year prospects: Dianomi

New Year prospects: Actual Experience

Aquis weekly movers: Hydrogen Utopia delays Main Market switch

New Year prospects: Victoria

New Year prospects: Portmeirion Group

AIM weekly movers: Tekmar recovers but no news on strategic investor

New Year prospects: Likewise Group

Crystal Amber plan to revitalise Hurricane Energy

AIM movers: MS International new weapon sale and Gfinity loss

City of London Group liquidation and distribution of Recognise Bank shares

Braveheart Investment cuts Velocity Composites stake

Journeo acquisition increases exposure to rail sector

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020